Literature DB >> 7514440

Immunofluorescence analysis of B-1 cell ontogeny in the mouse.

A M Hamilton1, A Lehuen, J F Kearney.   

Abstract

In order to further understand the developmental aspects of B-1 cells, we characterized the ontogeny of this B cell population in the spleen and peritoneal cavity of BALB/c mice. Although there are B-1 cells in the spleen within the first 1-3 weeks after birth, they do not at any stage represent the majority of splenic B cells. Splenic B-1 cells reach peak levels at approximately 9 days after birth. The mesenteric lining that covers the small intestine of 7-day-old mice contains a population of IgM+ B cells, while at the same age, there are few lymphoid cells in the peritoneal cavity. Between 7 and 8 days after birth there is an influx of B cells into the peritoneal cavity. At 8 days, the first detectable peritoneal B cells appear to be of the B-1 type based on expression of IL-5 receptor and CD5. However, these peritoneal B-1 cells do not express Mac-1. This antigen is not expressed by the majority of peritoneal B-1 cells until 3 weeks. This study indicates that the majority of early splenic B cells are not B-1 cells and it suggests that the mesenteric tissues surrounding the gut contain B lymphocytes which traffic into the peritoneal cavity where they then reside.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514440     DOI: 10.1093/intimm/6.3.355

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  12 in total

1.  X-chromosome-linked immune-deficient mice have B-1b cells.

Authors:  J Riggs; K Howell; B Matechin; R Matlack; A Pennello; R Chiasson
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

2.  Changes in the cytokine profile of lupus-prone mice (NZB/NZW)F1 induced by Plasmodium chabaudi and their implications in the reversal of clinical symptoms.

Authors:  M N Sato; P Minoprio; S Avrameas; T Ternynck
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

3.  Appearance of B220low autoantibody-producing B-1 cells at neonatal and older stages in mice.

Authors:  S Tachikawa; T Kawamura; H Kawamura; Y Kanda; Y Fujii; H Matsumoto; T Abo
Journal:  Clin Exp Immunol       Date:  2008-07-18       Impact factor: 4.330

4.  Noncoordinate expression of J-chain and Blimp-1 define nurse shark plasma cell populations during ontogeny.

Authors:  Caitlin D Castro; Yuko Ohta; Helen Dooley; Martin F Flajnik
Journal:  Eur J Immunol       Date:  2013-08-27       Impact factor: 5.532

Review 5.  The role of B cells and accessory cells in the neonatal response to TI-2 antigens.

Authors:  Cheri D Landers; R Lakshman Chelvarajan; Subbarao Bondada
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

6.  Pulmonary α-1,3-Glucan-Specific IgA-Secreting B Cells Suppress the Development of Cockroach Allergy.

Authors:  Preeyam S Patel; R Glenn King; John F Kearney
Journal:  J Immunol       Date:  2016-08-31       Impact factor: 5.422

7.  Neonatal Exposure to Commensal-Bacteria-Derived Antigens Directs Polysaccharide-Specific B-1 B Cell Repertoire Development.

Authors:  J Stewart New; Brian L P Dizon; Christopher F Fucile; Alexander F Rosenberg; John F Kearney; R Glenn King
Journal:  Immunity       Date:  2020-06-30       Impact factor: 31.745

8.  Roles for BLyS family members in meeting the distinct homeostatic demands of innate and adaptive B cells.

Authors:  Vishal J Sindhava; Jean L Scholz; Michael P Cancro
Journal:  Front Immunol       Date:  2013-02-25       Impact factor: 7.561

9.  A CD25⁻ positive population of activated B1 cells expresses LIFR and responds to LIF.

Authors:  Joseph R Tumang; Nichol E Holodick; Teresa C Vizconde; Hiroaki Kaku; Rubén Francés; Thomas L Rothstein
Journal:  Front Immunol       Date:  2011-03-21       Impact factor: 7.561

Review 10.  The Cellular Bases of Antibody Responses during Dengue Virus Infection.

Authors:  Juan Carlos Yam-Puc; Leticia Cedillo-Barrón; Elsa Maribel Aguilar-Medina; Rosalío Ramos-Payán; Alejandro Escobar-Gutiérrez; Leopoldo Flores-Romo
Journal:  Front Immunol       Date:  2016-06-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.